(BBIO) BridgeBio Pharma - Performance 38.4% in 12m
Compare BBIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
4.44%
#35 in Group
Rel. Strength
87.56%
#996 in Universe
Total Return 12m
38.37%
#31 in Group
Total Return 5y
11.00%
#37 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -6.97%
(?) Percentile in Group
12m Total Return: BBIO (38.4%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: BBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BBIO
Total Return (including Dividends) | BBIO | XBI | S&P 500 |
---|---|---|---|
1 Month | -5.35% | -10.94% | -6.73% |
3 Months | -5.01% | -14.92% | -11.93% |
12 Months | 38.37% | -6.46% | 7.24% |
5 Years | 11.00% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | BBIO | XBI | S&P 500 |
1 Month | -32.2% | -52.8% | -63.5% |
3 Months | -14.0% | -92.8% | -90.3% |
12 Months | 54.7% | -32.4% | 60.6% |
5 Years | -31.9% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #76 | 6.28% | 1.49% |
3 Month | #50 | 11.7% | 7.85% |
12 Month | #31 | 47.9% | 29.0% |
5 Years | #37 | 37.4% | -44.7% |
FAQs
Does BBIO BridgeBio Pharma outperforms the market?
Yes,
over the last 12 months BBIO made 38.37%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months BBIO made -5.01%, while XBI made -14.92%.
Over the last 3 months BBIO made -5.01%, while XBI made -14.92%.
Performance Comparison BBIO vs Indeces and Sectors
BBIO vs. Indices BBIO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.22% | 1.38% | 50.9% | 31.1% |
US NASDAQ 100 | QQQ | 1.74% | 2.01% | 50.7% | 30.8% |
US Dow Jones Industrial 30 | DIA | 4.25% | 1.56% | 50.2% | 33.9% |
German DAX 40 | DAX | 1.0% | -1.41% | 31.0% | 18.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.79% | -1.96% | 49.7% | 29.2% |
Hongkong Hang Seng | HSI | -0.45% | -1.63% | 46.3% | 21.6% |
India NIFTY 50 | INDA | 0.07% | -7.38% | 47.5% | 35.4% |
Brasil Bovespa | EWZ | -2.05% | -5.81% | 45.8% | 47.1% |
BBIO vs. Sectors BBIO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.51% | 1.50% | 41.7% | 23.3% |
Consumer Discretionary | XLY | 0.78% | 1.49% | 45.6% | 27.1% |
Consumer Staples | XLP | 2.07% | -8.33% | 42.9% | 27.0% |
Energy | XLE | 2.15% | 7.15% | 52.2% | 51.1% |
Financial | XLF | 1.52% | -0.50% | 42.0% | 20.5% |
Health Care | XLV | 4.49% | 2.41% | 53.1% | 40.8% |
Industrial | XLI | 2.82% | 0.68% | 51.0% | 34.3% |
Materials | XLB | 2.48% | 0.50% | 58.1% | 44.3% |
Real Estate | XLRE | 2.45% | -2.12% | 51.2% | 23.6% |
Technology | XLK | 1.95% | 3.65% | 57.1% | 37.2% |
Utilities | XLU | 2.33% | -5.55% | 47.2% | 16.7% |
Aerospace & Defense | XAR | 3.67% | -2.17% | 41.5% | 16.5% |
Biotech | XBI | -1.20% | 5.59% | 62.3% | 44.8% |
Homebuilder | XHB | 0.69% | 2.77% | 65.6% | 48.9% |
Retail | XRT | 0.35% | 0.04% | 54.3% | 44.7% |